Ch. Marth

1.1k total citations
50 papers, 811 citations indexed

About

Ch. Marth is a scholar working on Molecular Biology, Immunology and Reproductive Medicine. According to data from OpenAlex, Ch. Marth has authored 50 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 8 papers in Reproductive Medicine. Recurrent topics in Ch. Marth's work include Retinoids in leukemia and cellular processes (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Immunotherapy and Immune Responses (4 papers). Ch. Marth is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Immunotherapy and Immune Responses (4 papers). Ch. Marth collaborates with scholars based in Austria, Germany and Norway. Ch. Marth's co-authors include G. Daxenbichler, Geertruida H. de Bock, Günther Gastl, Brigitte Eibl, Lawrence R. Schiller, David Nachbaur, C. Gassner, Anne Gächter, Rudolf Knapp and H Schwaighofer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ch. Marth

44 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ch. Marth Austria	14	289	277	235	193	99	50	811
Hisako Inoue Japan	17	275 1.0×	194 0.7×	205 0.9×	230 1.2×	29 0.3×	42	834
XX Du United States	11	374 1.3×	262 0.9×	297 1.3×	194 1.0×	13 0.1×	18	790
Robert H. Rudolph United States	17	197 0.7×	387 1.4×	263 1.1×	118 0.6×	16 0.2×	30	904
Peter Noertersheuser United States	10	181 0.6×	118 0.4×	63 0.3×	141 0.7×	57 0.6×	22	626
Jörg Bläser Germany	14	82 0.3×	176 0.6×	199 0.8×	197 1.0×	78 0.8×	20	778
M. Brandely France	14	326 1.1×	164 0.6×	262 1.1×	119 0.6×	8 0.1×	36	760
Jan Kornafel Poland	16	182 0.6×	67 0.2×	411 1.7×	246 1.3×	18 0.2×	73	832
M Kowalska Poland	16	236 0.8×	34 0.1×	448 1.9×	231 1.2×	105 1.1×	56	888
Charles E. Welander United States	16	117 0.4×	49 0.2×	192 0.8×	184 1.0×	248 2.5×	36	861
Sung‐Chao Chu Taiwan	11	131 0.5×	82 0.3×	94 0.4×	86 0.4×	23 0.2×	37	948

Countries citing papers authored by Ch. Marth

Since Specialization

Citations

This map shows the geographic impact of Ch. Marth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Marth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Marth more than expected).

Fields of papers citing papers by Ch. Marth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. Marth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Marth. The network helps show where Ch. Marth may publish in the future.

Co-authorship network of co-authors of Ch. Marth

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. Marth. A scholar is included among the top collaborators of Ch. Marth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. Marth. Ch. Marth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marth, Ch., et al.. (2018). Corrections to “Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Annals of Oncology. 29. iv262–iv262. 92 indexed citations

Stadlmann, Sylvia, Clara Natoli, Martin Widschwendter, et al.. (2001). Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.. PubMed. 20(6B). 4507–11. 7 indexed citations

Marth, Ch., Martin Widschwendter, J. Kærn, et al.. (1997). Cisplatin resistance is associated with reduced interferon-γ-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells. British Journal of Cancer. 76(10). 1328–1332. 26 indexed citations

Marth, Ch., Gabriele Werner‐Felmayer, Clara Natoli, et al.. (1996). Tumor-associated antigen 90K activates myelomonocytic cell line THP-1. Cancer Letters. 107(1). 143–148. 13 indexed citations

Deusch, Engelbert, Norbert Reider, & Ch. Marth. (1996). Anaphylactic reaction to latex during cesarean delivery. Obstetrics and Gynecology. 88(4). 727–727. 14 indexed citations

Volgger, Birgit, et al.. (1996). Sonomorphologische Beurteilung des postmenopausalen Endometriums. Gyn�kologisch-geburtshilfliche Rundschau. 36(1). 21–28. 3 indexed citations

Zeimet, Alain G., et al.. (1993). Klinische Relevanz von reaktiven Thrombozytosen bei Patientinnen mit Ovariaikarzinomen. Gyn�kologisch-geburtshilfliche Rundschau. 33(1). 217–218. 1 indexed citations

Hetzel, H., et al.. (1993). Photodynamische Therapie bei Patientinnen mit Rezidiven gynäkologischer Karzinome. Geburtshilfe und Frauenheilkunde. 53(5). 333–336. 3 indexed citations

Marth, Ch., et al.. (1990). Prognostisch relevante Faktoren beim malignen Müllerschen Mischtumor. Geburtshilfe und Frauenheilkunde. 50(8). 605–609. 2 indexed citations

10.

Lechner, Wolfgang, et al.. (1989). Calcium Antagonists for Uterine Relaxation. Gynecologic and Obstetric Investigation. 28(3). 144–146. 2 indexed citations

11.

Lechner, Wolfgang, et al.. (1989). Calcium and calmodulin antagonism for inhibition of uterine contractions. Archives of Gynecology and Obstetrics. 244(3). 137–139. 1 indexed citations

12.

Daxenbichler, G., Ch. Marth, H. Baumgartner, et al.. (1988). Endokrinologische Untersuchungen bei Anorexia nervosa unter gesicherter Kalorienzufuhr. Gyn�kologisch-geburtshilfliche Rundschau. 28(2). 93–95.

13.

Marth, Ch., et al.. (1988). Retinoic binding in melanomas of the eye and in normal choroid. Cancer Letters. 41(1). 119–122. 3 indexed citations

14.

Marth, Ch., Günther Gastl, Peter Zilla, et al.. (1987). Characterization of an Interferon-Resistant Mutant of the Human Breast Cancer Cell Line BT-20. Journal of Interferon Research. 7(2). 195–202. 3 indexed citations

15.

Daxenbichler, G., et al.. (1987). Retinoic Acid- and Retinol Binding Proteins in Melanomas and Retinoblastomas. Ophthalmologica. 194(2-3). 126–127. 3 indexed citations

16.

Tilg, Herbert, R Margreiter, M. Scriba, et al.. (1987). Clinical presentation of CMV infection in solid organ transplant recipients and its impact on graft rejection and neopterin excretion. Clinical Transplantation. 1(1). 37–43. 13 indexed citations

17.

Marth, Ch., et al.. (1987). Effects of retinoids and interferon‐gamma on cultured breast cancer cells in comparison with tumor necrosis factor alpha. International Journal of Cancer. 40(6). 840–845. 24 indexed citations

18.

Denz, H., Monika Lechleitner, Ch. Marth, et al.. (1985). Effect of Human Recombinant Alpha-2-and Gamma-Interferon on the Growth of Human Cell Lines from Solid Tumors and Hematologic Malignancies. Journal of Interferon Research. 5(1). 147–157. 61 indexed citations

19.

Marth, Ch., Ferdinand Hofstädter, Gertrude Case Buehring, & G. Daxenbichler. (1983). Tamoxifen and its metabolites: binding to the estrogen receptor and growth effects on breast cancer cells. University of Regensburg Publication Server (University of Regensburg). 1 indexed citations

20.

Daxenbichler, G., et al.. (1983). Vitamin A Status and Retinoid-Binding Proteins in Carcinomas of the Head and Neck Region. Oncology. 40(5). 336–339. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact